Manometry System Market Size, Share, and Industry Analysis, By Type (Anorectal Manometry, Esophageal Manometry, and Others), By Application (Dysphagia, Fecal Incontinence, and Others), By End User (Hospitals, Diagnostic Centers, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global manometry system market is witnessing significant growth owing to the increasing prevalence of gastrointestinal disorders resulting in the rising focus of key players toward R&D activities to launch new systems. Manometry systems measure the muscle contractions of the esophagus which helps in the diagnosis of gastrointestinal conditions among the patient population.

• According to 2021 data published by the National Center for Biotechnology Information (NCBI), it was reported that more than 40% of persons have functional gastrointestinal disorders (FGIDs) globally.

Manometry System Market Driver

Increasing Prevalence of Gastrointestinal Disorders to Drive Market Growth

The increasing prevalence of disorders such as swallowing problems, dysphagia, and others among the patient population is resulting in the rising focus of key players to develop and introduce innovative manometry systems. In addition, a growing number of key players focusing on acquisitions and mergers among the major players is likely to support the segment growth.

• According to 2021 statistics published by the American Speech Language Hearing Association (ASHA), it was reported that one in 25 adults experience a swallowing problem in the U.S.

Download Free sample to learn more about this report.

According to 2024 data published by Nature, it was reported that the prevalence of functional constipation is 9.3%, functional dyspepsia is 10.7%, irritable bowel syndrome is 6.8%, and fecal incontinence is 1.0% in China.

Manometry System Market Restraint

Limited Number of Healthcare Facilities in Emerging Countries to Hinder Market Growth

There is a growing demand for technologically advanced manometry systems to diagnose gastrointestinal disorders globally. However, the limited awareness about these systems, along with a reduced number of healthcare facilities in emerging countries such as Brazil, China, and others, is expected to limit the adoption rate of these products.

• According to 2023 statistics published by the Brazilian Federation of Hospitals, it was reported that there are about 7,191 hospitals in Brazil.

Manometry System Market Opportunity

Surging Demand for Manometry to Bolster Future Growth Opportunities

There is a growing demand for medical services, including anorectal and esophageal manometry, and others, further resulting in the focus of healthcare facilities toward the establishment of new gastrointestinal physiology labs providing these services. This is likely to support the adoption rate of these devices.

• In June 2021, KMC Hospital established a new gastrointestinal physiology lab with the introduction of anorectal and esophageal manometry services in India.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Disorders, By Key Countries/Regions, 2023
• New Product Launches, By Key Players
• Overview: Technological Advancements in Manometry System
• Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• Impact of COVID-19 on the Market

Analysis by Type

Based on type, the market is fragmented into anorectal manometry, esophageal manometry, and others.

The esophageal manometry segment accounted for a substantial market share in 2023. The increasing focus of major players on research and development activities to launch novel manometry systems is expected to contribute to the segmental growth. In addition, the rising focus of healthcare facilities on the establishment of gastrointestinal motility centers to provide medical services such as esophageal manometry, is expected to support the segmental growth.

• In February 2024, Manipal Hospitals, one of India’s healthcare providers, established the gastrointestinal motility center at the hospital which is aimed to provide medical services including esophageal manometry among the patient population.

Analysis by Application

In terms of application, the market is divided into dysphagia, fecal incontinence, and others.

The dysphagia segment accounted for a prominent market share in 2023. The segmental growth is due to the rising prevalence of dysphagia among the patient population, resulting in a growing diagnosis rate for these disorders, supporting the adoption rate for these manometry systems in the market.

• According to 2024 data published by the National Center for Biotechnology Information (NCBI), about 64.2% of people are suffering from dysphagia in Africa.

Analysis by End User

On the basis of end user, the market is subdivided into hospitals, diagnostic centers, specialty clinics, and others.

The hospitals segment dominates the market in 2023. The growth is owing to the surging number of hospitals, further supporting the rising adoption rate of manometry systems among the patient population globally.

• According to 2023 statistics published by the American Health Association (AHA), it was reported that there are about 6,120 hospitals in the U.S.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest market share in 2023. The growth is due to several factors, including the increasing prevalence of gastrointestinal disorders, developed healthcare infrastructure, increasing R&D activities, among others.

• According to 2022 statistics published by the American Gastroenterological Association (AGA), about 60-70 million Americans are suffering from gastrointestinal diseases in the U.S.

Additionally, Europe is the second-largest market for manometry systems. The rising geriatric population is resulting in the growing prevalence of gastrointestinal conditions, which is further contributing to the demand for innovative manometry systems in the market. This, along with the rising focus of key players toward strategic initiatives, including acquisitions and mergers, among others, is further likely to support the regional market growth.

• According to a 2023 article published by The Lancet, it was reported that over 332 million people are suffering from gastrointestinal diseases in Europe.

The Asia Pacific region is also expected to grow at a considerable CAGR during the forecast period. The growth is due to the surging number of prominent players operating in the market offering technologically advanced manometry systems.

Key Players Covered

The market is semi-consolidated, with few players operating in the global market.

The report includes the profiles of the following key players:

• Medtronic (Ireland)
• Laborie (U.S.)
• MEDSPIRA (U.S.)
• Mui Scientific (Canada)
• Alacer Biomédica (Brazil)
• EB Neuro S.p.A. (Italy)

Key Industry Developments

• In December 2024, Medtronic collaborated with Yashoda Super Specialty Hospital to provide manometry training in Kaushambi. This helped the company increase its global brand presence.
• In May 2024, Laborie Medical Technologies launched the Solar Anorectal Manometry Catheter and Solar Compact System with an aim to improve the diagnosis of gastrointestinal disorders among the patient population.

  The global manometry system market is witnessing significant growth owing to the increasing prevalence of gastrointestinal disorders resulting in the rising focus of key players toward R&D activities to launch new systems. Manometry systems measure the muscle contractions of the esophagus which helps in the diagnosis of gastrointestinal conditions among the patient population.

  • According to 2021 data published by the National Center for Biotechnology Information (NCBI), it was reported that more than 40% of persons have functional gastrointestinal disorders (FGIDs) globally.

  Manometry System Market Driver

  Increasing Prevalence of Gastrointestinal Disorders to Drive Market Growth

  The increasing prevalence of disorders such as swallowing problems, dysphagia, and others among the patient population is resulting in the rising focus of key players to develop and introduce innovative manometry systems. In addition, a growing number of key players focusing on acquisitions and mergers among the major players is likely to support the segment growth.

  • According to 2021 statistics published by the American Speech Language Hearing Association (ASHA), it was reported that one in 25 adults experience a swallowing problem in the U.S.

  Prevalence of Functional Gastrointestinal Disorders (FGIDs), Hainan Province, China, 2024

  According to 2024 data published by Nature, it was reported that the prevalence of functional constipation is 9.3%, functional dyspepsia is 10.7%, irritable bowel syndrome is 6.8%, and fecal incontinence is 1.0% in China.

  Manometry System Market Restraint

  Limited Number of Healthcare Facilities in Emerging Countries to Hinder Market Growth

  There is a growing demand for technologically advanced manometry systems to diagnose gastrointestinal disorders globally. However, the limited awareness about these systems, along with a reduced number of healthcare facilities in emerging countries such as Brazil, China, and others, is expected to limit the adoption rate of these products.

  • According to 2023 statistics published by the Brazilian Federation of Hospitals, it was reported that there are about 7,191 hospitals in Brazil.

  Manometry System Market Opportunity

  Surging Demand for Manometry to Bolster Future Growth Opportunities

  There is a growing demand for medical services, including anorectal and esophageal manometry, and others, further resulting in the focus of healthcare facilities toward the establishment of new gastrointestinal physiology labs providing these services. This is likely to support the adoption rate of these devices.

  • In June 2021, KMC Hospital established a new gastrointestinal physiology lab with the introduction of anorectal and esophageal manometry services in India.

  Segmentation

  By Type	By Application	By End User	By Geography
  Anorectal Manometry Esophageal Manometry Others	Dysphagia Fecal Incontinence Others	Hospitals Diagnostic Centers Specialty Clinics Others	North America (U.S. and Canada) Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

  Key Insights

  The report covers the following key insights:

  • Prevalence of Key Disorders, By Key Countries/Regions, 2023
  • New Product Launches, By Key Players
  • Overview: Technological Advancements in Manometry System
  • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • Impact of COVID-19 on the Market

  Analysis by Type

  Based on type, the market is fragmented into anorectal manometry, esophageal manometry, and others.

  The esophageal manometry segment accounted for a substantial market share in 2023. The increasing focus of major players on research and development activities to launch novel manometry systems is expected to contribute to the segmental growth. In addition, the rising focus of healthcare facilities on the establishment of gastrointestinal motility centers to provide medical services such as esophageal manometry, is expected to support the segmental growth.

  • In February 2024, Manipal Hospitals, one of India’s healthcare providers, established the gastrointestinal motility center at the hospital which is aimed to provide medical services including esophageal manometry among the patient population.

  Analysis by Application

  In terms of application, the market is divided into dysphagia, fecal incontinence, and others.

  The dysphagia segment accounted for a prominent market share in 2023. The segmental growth is due to the rising prevalence of dysphagia among the patient population, resulting in a growing diagnosis rate for these disorders, supporting the adoption rate for these manometry systems in the market.

  • According to 2024 data published by the National Center for Biotechnology Information (NCBI), about 64.2% of people are suffering from dysphagia in Africa.

  Analysis by End User

  On the basis of end user, the market is subdivided into hospitals, diagnostic centers, specialty clinics, and others.

  The hospitals segment dominates the market in 2023. The growth is owing to the surging number of hospitals, further supporting the rising adoption rate of manometry systems among the patient population globally.

  • According to 2023 statistics published by the American Health Association (AHA), it was reported that there are about 6,120 hospitals in the U.S.

  Regional Analysis

  Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

  North America accounted for the largest market share in 2023. The growth is due to several factors, including the increasing prevalence of gastrointestinal disorders, developed healthcare infrastructure, increasing R&D activities, among others.

  • According to 2022 statistics published by the American Gastroenterological Association (AGA), about 60-70 million Americans are suffering from gastrointestinal diseases in the U.S.

  Additionally, Europe is the second-largest market for manometry systems. The rising geriatric population is resulting in the growing prevalence of gastrointestinal conditions, which is further contributing to the demand for innovative manometry systems in the market. This, along with the rising focus of key players toward strategic initiatives, including acquisitions and mergers, among others, is further likely to support the regional market growth.

  • According to a 2023 article published by The Lancet, it was reported that over 332 million people are suffering from gastrointestinal diseases in Europe.

  The Asia Pacific region is also expected to grow at a considerable CAGR during the forecast period. The growth is due to the surging number of prominent players operating in the market offering technologically advanced manometry systems.

  Key Players Covered

  The market is semi-consolidated, with few players operating in the global market.

  The report includes the profiles of the following key players:

  • Medtronic (Ireland)
  • Laborie (U.S.)
  • MEDSPIRA (U.S.)
  • Mui Scientific (Canada)
  • Alacer Biomédica (Brazil)
  • EB Neuro S.p.A. (Italy)

  Key Industry Developments

  • In December 2024, Medtronic collaborated with Yashoda Super Specialty Hospital to provide manometry training in Kaushambi. This helped the company increase its global brand presence.
  • In May 2024, Laborie Medical Technologies launched the Solar Anorectal Manometry Catheter and Solar Compact System with an aim to improve the diagnosis of gastrointestinal disorders among the patient population.